July 31, 2013 development status, PDF file Takeda website pg 2. A reference point for tomorrows reporting, if nothing else comes out.
The process has moved a step forward. Looking for resubmission now. Might want to read up on the latest publication report on the subject matter. Great read!!!!!
I think they state that a resubmission is pending the outcome of the US investigation- not that they have moved a step forward and a planning a resubmission. If you find otherwise, please indicate where. thanks
How has the process taken a step forward?
I wonder why they list only the EU as their market, excluding the US.
US big pharm does not want the science behind the drug to advance. The department of internal medicine in Germany has a different point of view.